Evidence map›Paper›PMID 36134116›Full record

ArticleContrast media & molecular imaging2022

Study on the Effects of Different Doses of Dahuang Zhechong Pills on the Ubiquitin Proteasome Pathway/Nuclear Factor-

Peng Chen, Xuan Cui, Xi Chen, Zhengyu Chen, Xia Zhang, Chengrong Zhang, Jinyu Zhang

RetractedOpen access · hybridFull text readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Contrast media & molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Peng ChenDepartment of Cardiovascular Disease, First Hospital Affiliated to Heilongjiang University of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Xuan CuiDepartment of CT Magnetic Resonance, First Hospital Affiliated to Heilongjiang University of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China.ORCID 0000-0002-6991-2089
Xi ChenDepartment of Kidney Disease, First Hospital Affiliated to Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, China.
Zhengyu ChenDepartment of Cardiovascular Disease, First Hospital Affiliated to Heilongjiang University of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Xia ZhangDepartment of Cardiovascular Disease, First Hospital Affiliated to Heilongjiang University of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Chengrong ZhangDepartment of Cardiovascular Disease, First Hospital Affiliated to Heilongjiang University of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Jinyu ZhangDepartment of Cardiovascular Disease, First Hospital Affiliated to Heilongjiang University of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Heilongjiang University of Chinese Medicine · CNFirst Affiliated Hospital of Heilongjiang University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to investigate the effects of different doses of Dahuang Zhechong pills on the ubiquitin proteasome pathway/nuclear factor-

Indexed as

AtherosclerosisNF-kappa BAnimalsCholesterol, LDLDrugs, Chinese HerbalMaleProteasome Endopeptidase ComplexProteasome InhibitorsRatsRats, WistarSimvastatinTissue Plasminogen ActivatorTriglyceridesTumor Necrosis Factor-alphaUbiquitinsVitaminsCholesterol, LDLDahuang Zhechong pillDrugs, Chinese HerbalNF-kappa BProteasome Endopeptidase ComplexProteasome InhibitorsSimvastatinTissue Plasminogen ActivatorTriglyceridesTumor Necrosis Factor-alphaUbiquitinsVitamins

Identifiers

PMID36134116
PMCPMC9482499
OpenAlexW4295107478

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.